OakChart

Tango Therapeutics Inc

TNGXHealthcare·Biotechnology·USA·Mid·NASD·Nov 11 • 3:59 PM ET

25.73+1.43 (5.88%)
2026-11-12 04:33 CET
Market cap
4,338.34 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-208.00 USD m
Free cash flow, TTM
-150.36 USD m
EPS diluted, TTM
-1.37
P/E
-
Compare

Price

TNGX against its 20, 50 and 200-day averages
2050200miss
20.0030.0010.9M21.8MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26TNGXclose 25.7320-day 23.3850-day 23.42200-day 22.7625.7352w high

25.2% under the 52-week high of 34.39 on 17 Jun 2026. 52-week low 7.49 on 13 Nov 2025. Last 15 sessions, 34.9% high to low

Volume 1.15× normal · the line is the 50-bar volume average

Profile

TNGX
52-week range, 68% of the way up
7.4934.39

Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin Jr., Jose Baselga, Antoni Ribas and Barbara Weber in 2017 and is headquartered in Boston, MA.

IndexRUT
Employees137
IPOSep 03, 2020
Beta1.22
ATR, 14d1.96
Rel volume1.15
Short float38.66%
Insider own26.37%
Inst own110.98%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap4.36B
Enterprise Value3.41B
Income-208.00M
Sales0.00M
Book/sh5.79
Cash/sh5.77
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees137
IPOSep 03, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B4.44
P/C4.46
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio39.45
Current Ratio39.45
Debt/Eq0.03
LT Debt/Eq0.03
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.37
EPS next Y-1.79
EPS next Q-0.41
EPS this Y-71.39%
EPS next Y-20.22%
EPS next 5Y-
EPS past 3/5Y10.79% 11.68%
Sales past 3/5Y35.89% 52.13%
EPS Y/Y TTM-49.92%
Sales Y/Y TTM-100.00%
EPS Q/Q-374.77%
Sales Q/Q-100.00%
EarningsNov 09 BMO
EPS/Sales Surpr.-10.48% -

Ownership

Insider Own26.37%
Insider Trans-0.35%
Inst Own110.98%
Inst Trans15.73%
ROA-33.45%
ROE-36.48%
ROIC-20.63%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA2010.05%
SMA509.86%
SMA20013.06%
Trades-

Technical

Shs Outstand169.21M
Shs Float124.77M
Short Float38.66%
Short Ratio14.41
Short Interest48.24M
52W High34.39 -25.18%
52W Low7.49 243.52%
Volatility10.21% 8.40%
ATR (14)1.96
RSI (14)58.44
Beta1.22
Rel Volume1.15
Avg Volume3.35M
Volume3,867,465

Performance

Perf Week11.00%
Perf Month15.80%
Perf Quarter0.31%
Perf Half Y0.86%
Perf YTD190.41%
Perf Year207.04%
Perf 3Y207.78%
Perf 5Y98.38%
Perf 10Y-
Recom1.15
Target Price47.00
Prev Close24.30
Price25.73
Change %5.88%

Analyst ratings

latest 10 of 16
DateActionAnalystRating changeTargetImplied
Oct 16, 2026InitiatedWWilliam BlairOutperform
Jul 15, 2026InitiatedJJP MorganOverweight$46+78.8%
Jun 26, 2026UpgradeJJefferiesHold → Buy$60+133.2%
Jun 08, 2026UpgradeWWolfe ResearchPeer Perform → Outperform
May 15, 2026DowngradePPiper SandlerOverweight → Neutral$24-6.7%
May 14, 2026DowngradeJJefferiesBuy → Hold$27+4.9%
Apr 02, 2026InitiatedCCanaccord GenuityBuy$30+16.6%
Feb 23, 2026InitiatedMMizuhoOutperform$19-26.2%
Nov 18, 2025InitiatedWWolfe ResearchPeer Perform
Aug 19, 2025InitiatedPPiper SandlerOverweight$11-57.2%

Peers

Mkt cap
TickerCompanyMkt cap
IDYAIdeaya Biosciences Inc3.16B
RVMDRevolution Medicines Inc39.08B
ERASErasca Inc5.88B
RLAYRelay Therapeutics Inc4.36B
ELVNEnliven Therapeutics Inc3.77B
NUVBNuvation Bio Inc1.52B
BBOTBridgeBio Oncology Therapeutics Inc205.24M
AMGNAMGEN Inc253.21B
BMYBristol-Myers Squibb Co128.59B
PRLDPrelude Therapeutics Inc301.66M

Insider trading

latest 14 of 37
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Crystal AdamPresident, R&DNov 02 '26Option Exercise2.915,00014,550120,743Nov 04 07:35 PM
Crystal AdamPresident, R&DNov 02 '26Sale22.425,000112,108115,743Nov 04 07:35 PM
Newcomb JessicaPrincipal Accounting OfficerNov 02 '26Sale22.427,031157,66152,090Nov 04 07:32 PM
ADAM CRYSTALOfficerNov 02 '26Proposed Sale22.7220,000454,400Nov 02 04:37 PM
Crystal AdamPresident, R&DOct 01 '26Option Exercise5.2027,000140,400142,743Oct 05 05:36 PM
Crystal AdamPresident, R&DOct 01 '26Sale24.4727,000660,796115,743Oct 05 05:36 PM
Newcomb JessicaPrincipal Accounting OfficerSep 22 '26Sale24.228,200198,61359,121Sep 24 07:41 PM
Jessica NewcombOfficerSep 22 '26Proposed Sale22.3315,231340,108Sep 22 04:14 PM
Crystal AdamPresident, R&DSep 01 '26Option Exercise5.2027,000140,400142,743Sep 03 04:01 PM
Crystal AdamPresident, R&DSep 01 '26Sale22.3727,000603,909115,743Sep 03 04:01 PM
Crystal AdamPresident, R&DAug 03 '26Option Exercise5.2027,000140,400142,743Aug 05 04:01 PM
Crystal AdamPresident, R&DAug 03 '26Sale27.2427,000735,517115,743Aug 05 04:01 PM
ADAM CRYSTALOfficerAug 03 '26Proposed Sale27.1881,0002,201,580Aug 03 04:47 PM
Crystal AdamPresident, R&DJul 01 '26Option Exercise5.2027,000140,400142,743Jul 02 07:23 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
IBBiShares Biotechnology ETFAUM: 11.36B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
VHTVanguard Health Care ETFAUM: 21.51B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-09-0.390-0.353-0.3900.000.0013
2026Q22026-08-11-0.370-0.317-0.3690.000.0013
2026Q12026-05-13-0.320-0.314-0.3170.000.5812
2025Q42026-03-05-0.290-0.318-0.2950.000.5011
2025Q32025-11-040.140-0.0510.14353.8153.809
2025Q22025-08-05-0.350-0.344-0.3523.186.708
2025Q12025-05-12-0.360-0.350-0.3625.396.737
2024Q42025-02-27-0.350-0.338-0.3474.128.0210
2024Q32024-11-06-0.270-0.367-0.26911.618.0710
2024Q22024-08-07-0.240-0.345-0.23619.887.6310
2024Q12024-05-08-0.350-0.310-0.3516.477.508
2023Q42024-03-18-0.320-0.274-0.3165.438.248
2023Q32023-11-08-0.230-0.337-0.22910.737.596
2023Q22023-08-07-0.230-0.326-0.23414.607.195
2023Q12023-05-09-0.320-0.352-0.3185.776.776
2022Q42023-03-27-0.330-0.355-0.3306.416.326

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-0.940-1.036-0.93837.0437.91
2022FY-1.230-1.257-1.23224.8624.78
2023FY-1.080-1.070-1.07636.5338.63
2024FY-1.190-1.201-1.19342.0746.01
2025FY-0.870-0.872-0.87062.3862.81
2026FY--1.491--0.00
2027FY--1.793--3.13
2028FY--2.067--44.57
2029FY--1.356--292.92
2030FY-1.133--837.79

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0911000.000.000.00
2026Q4S2026-10-1411000.000.000.00
2026Q4S2026-09-0410000.000.000.00
2026Q4S2026-08-1111000.000.000.00
2026Q4S2026-07-1411000.000.000.00
2026Q4S2026-06-1310000.000.000.00
2026Q4S2026-05-1411000.640.007.00
2026Q4S2026-04-0111000.640.007.00
2026Q4S2026-03-2610000.700.007.00
2026Q4S2026-03-059000.780.007.00
2026Q4S2026-02-206000.000.000.00
2026Q4S2026-02-015000.000.000.00
2026Q4S2026-01-186000.000.000.00
2026Q4S2025-12-026010.000.000.00

Estimate history

EPS, annual-1.628-0.938-1.232-1.076-1.193-0.875-1.374
Period202020212022202320242025TTM
EPS, quarterly-0.269-0.347-0.362-0.3520.143-0.295-0.317-0.369-0.393
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual7.65637.04224.8636.52742.06962.3840
Period202020212022202320242025TTM
Sales, quarterly11.6074.1175.3923.18153.8110000
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual40.37287.59888.179102.203107.729135.94169.206
Period202020212022202320242025MRQ
Shares, quarterly107.415107.729108.108110.871111.567135.94144.163168.38169.206
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Total Revenue0.0062.3842.0736.5324.8637.047.66
Cost of Goods Sold Incl. D&A1.792.282.502.424.031.971.62
Gross Profit-1.7960.1039.5734.1120.8335.086.03
Selling, General and Administrative Excl. Other226.75171.39185.16148.28131.9093.2758.23
Research and Development149.98129.88143.92115.20105.9177.6449.99
Other Operating Expense0.000.000.000.000.000.000.00
Operating Income-228.53-111.29-145.59-114.17-111.07-58.19-52.20
Interest Expense0.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.00
Net Income Before Taxes-208.05-101.59-130.09-101.61-108.12-57.94-51.97
Income Taxes-0.050.000.210.130.050.290.00
Consolidated Net Income-208.00-101.59-130.30-101.74-108.18-58.23-51.97
Net Income From Continuing Operations-208.00-101.59-130.30-101.74-108.18-58.23-51.97
Net Income-208.00-101.59-130.30-101.74-108.18-58.23-51.97
EPS (Recurring)-1.20-0.87-1.19-1.08-1.23-0.94-1.63
EPS (Basic, Before Extraordinaries)-1.37-0.87-1.19-1.08-1.23-0.94-1.63
EPS (Diluted)-1.37-0.87-1.19-1.08-1.23-0.94-1.63
EBITDA-226.75-109.01-143.10-111.76-107.04-56.22-50.58
Non-Operating Income (Expense)20.489.7015.5012.562.950.250.23
Other After Tax Adjustments0.000.000.000.000.000.000.00
Stock Option Compensation Expense46.2720.8822.8315.0710.395.721.76
Price To Sales Ratio-16.508.0225.6325.6118.3447.71
Gross Margin-96.3494.0693.3983.8094.6978.77
Operating Margin--178.39-346.09-312.57-446.79-157.09-681.82
Net Margin--162.85-309.73-278.54-435.14-157.21-678.84
Shares Outstanding169.21135.94107.73102.2088.1887.6040.37
Market Capitalization4,338.344,338.34331.921,009.70639.29957.76244.56

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue0.000.000.000.0053.813.185.394.12
Cost of Goods Sold Incl. D&A0.420.420.460.480.560.620.620.62
Gross Profit-0.42-0.42-0.46-0.4853.262.564.773.50
Selling, General and Administrative Excl. Other77.7059.3648.3141.3839.1843.5247.3044.41
Research and Development48.5136.7733.0731.6230.2632.1835.8233.94
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-78.12-59.78-48.77-41.8614.07-40.97-42.53-40.91
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-68.39-55.34-45.51-38.8015.87-38.82-39.84-37.62
Income Taxes0.000.000.00-0.06-0.010.040.030.05
Consolidated Net Income-68.39-55.34-45.51-38.7515.88-38.85-39.88-37.67
Net Income From Continuing Operations-68.39-55.34-45.51-38.7515.88-38.85-39.88-37.67
Net Income-68.39-55.34-45.51-38.7515.88-38.85-39.88-37.67
EPS (Recurring)-0.39-0.37-0.32-0.290.14-0.35-0.36-0.35
EPS (Basic, Before Extraordinaries)-0.39-0.37-0.32-0.290.14-0.35-0.36-0.35
EPS (Diluted)-0.39-0.37-0.32-0.290.14-0.35-0.36-0.35
EBITDA-77.70-59.36-48.31-41.3814.63-40.34-41.91-40.29
Non-Operating Income (Expense)9.724.453.263.061.802.152.693.29
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense19.6813.348.534.725.235.195.735.89
Price To Sales Ratio-87.0752.7018.6914.0223.293.697.98
Gross Margin----98.9780.3588.4684.94
Operating Margin----26.15-1,287.87-788.76-993.68
Net Margin----29.52-1,221.41-739.54-914.99
Shares Outstanding169.21168.38144.16135.94111.57110.87108.11107.73
Market Capitalization4,338.345,089.602,985.051,193.24934.58554.98148.11331.92

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY
Cash & Short Term Investments343.57257.92337.74366.70485.82190.32
Short Term Receivables0.000.000.002.002.002.00
Inventories0.000.000.000.000.000.00
Other Current Assets10.198.438.806.574.521.31
Total Current Assets353.76266.34346.54375.27492.34193.63
Net Property, Plant & Equipment42.4947.5853.4257.776.0911.30
Total Investments and Advances2.142.572.573.421.712.28
Intangible Assets-----0.00
Deferred Tax Assets11.3212.4513.9715.03--
Other Assets0.300.000.050.010.020.04
Total Assets410.01328.94416.53451.50500.15207.25
Short Term Debt Incl. Current Port. of LT Debt2.742.452.081.771.500.96
Accounts Payable1.181.602.794.453.231.84
Income Tax Payable--0.000.040.050.00
Other Current Liabilities17.7634.1241.0749.2935.9138.12
Total Current Liabilities21.6838.1745.9455.5540.6940.92
Long Term Debt30.8334.0436.8439.360.006.92
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities11.3212.4513.9715.03--
Other Liabilities0.0044.7766.6892.09114.72120.81
Total Liabilities63.83129.43163.43202.03155.41168.65
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity346.18199.52253.11249.48344.7538.60
Total Shareholders Equity346.18199.52253.11249.48344.7538.60
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity346.18199.52253.11249.48344.7538.60
Total Liabilities & Stockholders Equity410.01328.94416.53451.50500.15207.25
Book Value Per Share2.551.852.482.833.940.96
Tangible Book Value Per Share2.551.852.482.833.940.96
Full-Time Employees137155140110914
Price to Book Ratio4.441.453.652.342.781.51
Return on Assets-27.50-34.96-23.44-22.73-17.42-
Return on Equity-37.23-57.58-40.49-36.41-22.97-
Return on Invested Capital-26.95-55.79-35.09-37.45-16.89-114.16
Quick Ratio16.326.987.546.7612.104.73
Current Ratio16.326.987.546.7612.104.73

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Net Income-208.00-101.59-130.30-101.74-108.18-58.23-51.97
Depreciation1.792.282.502.424.031.971.62
Other Funds (Non Cash)57.4427.6328.0519.3113.568.091.75
Funds from Operations-148.77-71.69-99.75-80.02-90.59-48.18-48.60
Extraordinary Item0.000.000.000.000.000.000.00
Changes in Working Capital-1.32-67.20-31.75-37.97-18.49-11.35118.67
Income Taxes Payable------0.01
Cash from Operating Activities-150.09-138.89-131.50-117.98-109.08-59.5370.07
Capital Expenditures-0.28-1.05-0.75-1.53-7.69-1.84-1.11
Net Assets From Acquisitions0.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.00
Purchase or Sale of Investments-795.76-39.8286.8842.9534.09-181.60-144.32
Purchase of Investments-1,050.01-264.46-240.89-310.57-208.50-372.36-207.54
Sale Or Maturity of Investments254.25224.64327.77353.53242.59190.7663.22
Other Uses0.000.000.000.000.000.00-0.04
Other Sources0.000.000.000.000.000.000.00
Cash from Investing Activities-796.04-40.8786.1341.4326.40-183.43-145.47
Cash Dividends Paid0.000.000.000.000.000.000.00
Change in Capital Stock975.50222.5447.6681.961.6231.0580.88
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00
Sale of Common Pref Stock975.50222.5447.6681.961.6231.0580.88
Proceedsfrom Stock Options714.820.000.000.000.0029.9980.84
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow-1.31-0.040.000.45-0.01326.280.00
Other Financing Activities Uses-1.31-0.040.00-0.24-0.01-15.840.00
Cash from Financing Activities974.19222.5047.6682.411.61357.3280.88
Net Change in Cash28.0742.752.295.85-81.07114.365.49
Free Cash Flow-150.36-139.93-132.25-119.51-116.77-61.3668.97
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00
Price to Free Cash Flow------5.30
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments977.501,013.99379.84343.57153.24181.21
Short Term Receivables0.000.000.000.000.000.00
Inventories0.000.000.000.000.000.00
Other Current Assets15.1617.6812.4910.1910.548.89
Total Current Assets992.661,031.67392.33353.76163.78190.10
Net Property, Plant & Equipment38.4139.7641.0342.4943.9345.34
Total Investments and Advances2.142.142.142.142.142.14
Deferred Tax Assets---11.32--
Other Assets0.250.310.290.300.290.31
Total Assets1,033.461,073.88435.79410.01210.14237.89
Short Term Debt Incl. Current Port. of LT Debt3.062.942.832.743.102.53
Accounts Payable1.651.812.431.182.232.61
Other Current Liabilities20.4615.559.0717.7613.1134.88
Total Current Liabilities25.1620.3014.3321.6818.4440.02
Long Term Debt28.1229.0529.9630.8331.6632.47
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---11.32--
Other Liabilities0.000.000.000.000.0030.44
Total Liabilities53.2949.3544.2963.8350.10102.94
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity980.171,024.53391.51346.18160.03134.95
Total Shareholders Equity980.171,024.53391.51346.18160.03134.95
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity980.171,024.53391.51346.18160.03134.95
Total Liabilities & Stockholders Equity1,033.461,073.88435.79410.01210.14237.89
Book Value Per Share5.796.082.722.551.431.22
Tangible Book Value Per Share5.796.082.722.551.431.22
Full-Time Employees---137--
Price to Book Ratio4.4411.518.216.186.903.32
Return on Assets-33.45-18.86-30.20-27.50-35.74-47.01
Return on Equity-36.48-21.34-38.42-37.23-51.65-76.09
Return on Invested Capital-6.78-5.25-10.80-10.288.29-23.21
Quick Ratio39.4550.8227.3816.328.884.75
Current Ratio39.4550.8227.3816.328.884.75

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-68.39-55.34-45.51-38.7515.88-38.85
Depreciation0.420.420.460.480.560.62
Other Funds (Non Cash)23.7116.9210.676.157.046.87
Funds from Operations-44.27-38.00-34.38-32.1223.48-31.36
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital7.12-0.87-9.972.40-54.43-5.16
Cash from Operating Activities-37.14-38.87-44.36-29.72-30.95-36.52
Capital Expenditures-0.060.000.00-0.22-0.15-0.62
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses-0.020.020.000.000.000.00
Purchase or Sale of Investments-223.91-445.999.63-135.5047.6317.40
Purchase of Investments-301.49-519.10-54.41-175.02-18.34-23.94
Sale Or Maturity of Investments77.5873.1064.0539.5265.9741.34
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-223.98-445.979.63-135.7247.4816.78
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock3.04672.6680.38219.412.540.58
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock3.04672.6680.38219.412.540.58
Proceedsfrom Stock Options0.00652.0462.780.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.64-0.10-0.54-0.040.000.00
Other Financing Activities Uses-0.64-0.10-0.54-0.040.000.00
Cash from Financing Activities2.40672.5779.85219.382.540.58
Net Change in Cash-258.72187.7345.1253.9419.07-19.16
Free Cash Flow-37.20-38.87-44.36-29.94-31.10-37.14

Revenue breakdown

Collaboration2024: 29.97M 2025: 62.38M
License2024: 12.10M
United States2024: 42.07M 2025: 62.38M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3038.86%48.2M124.2M3.25M
2026-10-1536.07%44.8M124.2M2.79M
2026-09-3035.84%44.5M124.2M2.58M
2026-09-1533.73%41.9M124.1M3.02M
2026-08-3130.61%42.6M139.3M3.73M
2026-08-1434.79%43.2M124.1M3.89M
2026-07-3141.98%44.6M106.3M4.01M
2026-07-1540.20%42.7M106.3M4.16M
2026-06-3035.21%42.0M119.3M4.15M
2026-06-1528.53%34.0M119.3M3.65M
2026-05-2931.58%33.5M106.0M3.36M
2026-05-1530.00%31.8M106.0M3.40M
2026-04-3036.62%38.3M104.5M3.36M
2026-04-1540.10%40.2M100.4M3.30M
2026-03-3141.30%40.4M97.7M3.43M
2026-03-1348.34%47.2M97.7M3.35M
2026-02-2749.87%48.7M97.7M2.85M
2026-02-1350.98%47.0M92.3M2.94M
2026-01-3047.59%45.8M96.3M2.95M
2026-01-1544.24%42.8M96.7M3.44M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.0023.0026.800.000.0000.000.000.998-0.0170.000
call2.0022.0025.800.000.0000.000.000.997-0.0190.000
call3.0021.0024.800.0019.7410.000.000.989-0.0530.001
call4.0020.0023.800.0015.5600.000.000.987-0.0550.001
call5.0019.1022.800.0013.1650.000.000.985-0.0560.002
call6.0018.1021.800.0011.4980.000.000.982-0.0560.002
call7.0017.1020.800.0010.2260.000.000.980-0.0560.002
call8.0016.1019.800.009.2000.000.000.977-0.0560.002
call9.0015.0018.800.007.7060.000.000.940-0.1780.005
call10.0014.0017.7012.277.4377.000.000.972-0.0550.003
call11.0013.0016.9013.507.1051.000.000.969-0.0550.003
call12.0012.0015.900.006.5160.000.000.966-0.0540.003
call13.0011.0014.4010.155.3270.000.000.963-0.0530.003
call14.0010.0013.900.005.4980.000.000.959-0.0530.004
call15.009.0012.907.275.05036.000.000.954-0.0520.004
call16.008.0011.800.004.5270.000.000.949-0.0510.004
call17.007.0010.900.004.2410.000.000.944-0.0490.005
call18.006.008.800.002.8910.000.000.884-0.1010.008
call19.005.108.900.003.5200.000.000.929-0.0460.005
call20.004.107.304.182.31318.000.000.919-0.0440.006
call21.003.006.902.822.85718.000.000.783-0.1430.012
call22.002.254.703.821.8491141.000.755-0.1330.013
call23.001.104.501.101.9411830.000.720-0.1220.013
call24.000.703.501.301.7112160.000.662-0.1270.015
call25.001.253.402.051.9196119.000.597-0.1590.015
call26.000.852.451.651.6061,37822.000.543-0.1640.016
call27.000.052.500.901.8607530.000.497-0.1750.016
call28.000.150.750.750.98144274.000.335-0.0880.015
call29.000.001.651.051.15748.000.000.285-0.0900.014
call30.000.101.000.220.97823820.000.177-0.0580.010
call31.000.001.650.301.10821.000.000.161-0.0620.010
call32.000.001.650.661.2297430.000.149-0.0650.009
call33.000.001.654.031.3431.000.000.140-0.0680.009
call34.000.001.654.501.4512.000.000.132-0.0710.009
call35.000.001.650.151.55355.000.000.125-0.0730.008
call36.000.001.651.351.6505.000.000.120-0.0750.008
call37.000.001.651.801.7439.000.000.115-0.0770.008
call38.000.001.651.801.8322.000.000.111-0.0790.008
call39.000.001.651.001.9176.000.000.107-0.0800.007
call40.000.000.750.511.5427440.000.043-0.0320.004
call41.000.001.650.941.6108.000.000.042-0.0330.004
call42.000.002.950.751.6754.000.000.040-0.0330.003
call43.000.001.650.701.7385.000.000.039-0.0340.003
call44.000.001.650.701.77511.000.000.038-0.0340.003
call45.000.001.650.121.83426.000.000.037-0.0340.003
put1.000.000.050.049.6732.000.00-0.003-0.0150.000
put2.000.000.050.007.3390.000.00-0.004-0.0160.000
put3.000.001.650.009.8570.000.00-0.015-0.0850.002
put4.000.001.650.009.4220.000.00-0.023-0.1140.002
put5.000.001.650.008.2340.000.00-0.027-0.1180.003
put6.000.001.650.007.3130.000.00-0.032-0.1190.003
put7.000.001.650.006.5630.000.00-0.037-0.1200.003
put8.000.001.650.005.9300.000.00-0.042-0.1200.004
put9.000.001.650.305.3831.000.00-0.047-0.1200.004
put10.000.001.650.484.9012,0010.00-0.052-0.1190.004
put11.000.001.650.603.4082.000.00-0.031-0.0540.003
put12.000.001.650.804.0783.000.00-0.064-0.1160.005
put13.000.001.650.903.7204.000.00-0.071-0.1140.005
put14.000.001.650.503.01916.000.00-0.063-0.0840.005
put15.000.001.651.053.08210.000.00-0.086-0.1090.006
put16.000.001.651.202.7928.000.00-0.095-0.1060.007
put17.000.001.650.302.51816.000.00-0.105-0.1030.007
put18.000.001.650.452.25820.000.00-0.116-0.0990.008
put19.000.001.651.722.0083.000.00-0.129-0.0950.008
put20.000.000.600.201.7672,6369.00-0.145-0.0910.009
put21.000.001.701.152.1251060.00-0.217-0.1410.012
put22.000.001.801.461.85164.000.00-0.245-0.1310.013
put23.000.451.251.901.5782.000.00-0.280-0.1190.013
put24.000.101.500.711.47532.0010.00-0.338-0.1240.015
put25.000.402.352.991.7283220.00-0.403-0.1560.015
put26.000.903.404.502.05148.000.00-0.457-0.1610.016
put27.001.504.104.002.1152.000.00-0.503-0.1720.016
put28.002.104.800.002.1520.000.00-0.665-0.0850.015
put29.002.755.500.002.1650.000.00-0.715-0.0860.014
put30.003.606.407.202.28427.000.00-0.823-0.0550.010
put31.004.607.5012.042.5190.000.00-0.839-0.0580.010
put32.005.508.000.002.3430.000.00-0.851-0.0620.009
put33.006.309.000.002.4880.000.00-0.860-0.0640.009
put34.007.3010.0010.682.6240.000.00-0.868-0.0670.009
put35.008.3011.0016.602.7530.000.00-0.875-0.0690.008
put36.009.3012.000.002.8760.000.00-0.880-0.0710.008
put37.0010.3012.900.002.9190.000.00-0.885-0.0730.008
put38.0011.3013.900.003.0300.000.00-0.889-0.0740.008
put39.0012.3014.9015.893.1361.000.00-0.893-0.0760.007
put40.0013.3015.9017.503.2372.000.00-0.957-0.0280.004
put41.0013.6016.9018.103.2382.000.00-0.958-0.0280.004
put42.0014.6017.900.003.3300.000.00-0.960-0.0280.003
put43.0016.3018.9017.003.5191.000.00-0.961-0.0290.003
put44.0017.3019.9017.903.6060.000.00-0.962-0.0290.003
put45.0017.6021.0018.803.7690.000.00-0.963-0.0290.003

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-098-KCurrent report2026-11-09SEC
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-06SCHEDULE 13G/ASEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-10-238-KCurrent report2026-10-23SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-09-244Statement of changes in beneficial ownership of securities2026-09-22SEC
2026-09-22144Filing for proposed sale of securities under Rule 144.SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14SCHEDULE 13GSEC
2026-08-12SCHEDULE 13G/ASEC
2026-08-118-KCurrent report2026-08-11SEC
2026-08-11424B5SEC
2026-08-118-KCurrent report2026-08-11SEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-078-K/A2026-07-31SEC
2026-08-068-KCurrent report2026-07-31SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-03144Filing for proposed sale of securities under Rule 144.SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-19SEC
2026-06-233Initial statement of beneficial ownership of securities2026-06-19SEC
2026-06-238-KCurrent report2026-06-19SEC
2026-06-17144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100269.77K2
2026-1000660.80K1
2026-0900802.52K2
2026-0800735.52K1
2026-0700798.91K1
2026-0600617.57K1
2026-0500573.10K1
2026-04001.53M2
2026-0300545.09K2
2026-02001.42M4
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
RTW INVESTMENTS, LP8.54%
FMR LLC7.80%
BlackRock, Inc.7.64%
FARALLON CAPITAL MANAGEMENT, L.L.C.7.54%
Boxer Capital Management, LLC6.68%
GOLDMAN SACHS GROUP INC6.13%
TCG Crossover Management, LLC5.58%
TRV GP IV, LLC3.92%
Paradigm Biocapital Advisors LP3.90%
PRICE T ROWE ASSOCIATES INC /MD/3.90%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.70%
iShares Russell 2000 ETF2.22%
State Street(R) SPDR(R) S&P(R) Biotech ETF1.78%
Fidelity Growth Company Fund1.67%
Select Biotechnology Portfolio1.48%
T. Rowe Price New Horizons Fund, Inc.0.95%
Fidelity Small Cap Index Fund0.95%
T. Rowe Price Health Sciences Fund, Inc.0.86%
VANGUARD EXTENDED MARKET INDEX FUND0.84%
iShares Russell 2000 Growth ETF0.75%

OakChart. TNGX. Cached 15 minutes.